Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Erectile dysfunction and diastolic dysfunction treatments in men with metabolic syndrome
PACTR202604903325533Completed
- Sponsor
- Faculty of Medicine, Kafr Elsheikh University
- Start
- May 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label trial of tadalafil, dapagliflozin and empagliflozin in erectile dysfunction (ED) and cardiometabolic risk (CMR) (3 arms), sponsored by Faculty of Medicine, Kafr Elsheikh University. Started May 2025; status: completed.
02
Drugs
tadalafildapagliflozinempagliflozin
03
Conditions
erectile dysfunction (ED)cardiometabolic risk (CMR)
Beyond the preview
Go deeper on PACTR202604903325533.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR202604903325533.